Roche Holding AG
SIX:ROG

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SIX:ROG
Watchlist
Price: 270.5 CHF 0.26% Market Closed
Market Cap: 218.9B CHF

EV/EBIT
Enterprise Value to EBIT

11.4
Current
11.9
Median
16.3
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
11.4
=
Enterprise Value
229B CHF
/
EBIT
20.1B CHF
Market Cap EV/EBIT
CH
Roche Holding AG
SIX:ROG
215.2B CHF 11.4
US
Eli Lilly and Co
NYSE:LLY
773.2B USD 40.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
374.6B USD 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2.3T DKK 17.4
CH
Novartis AG
SIX:NOVN
190B CHF 14.2
UK
AstraZeneca PLC
LSE:AZN
169.1B GBP 197.9
US
Merck & Co Inc
NYSE:MRK
203.1B USD 10.5
IE
Endo International PLC
LSE:0Y5F
163.5B USD 655.3
US
Pfizer Inc
NYSE:PFE
139.4B USD 10.7
FR
Sanofi SA
PAR:SAN
108.7B EUR 5.6
EBIT Growth EV/EBIT to Growth
CH
Roche Holding AG
SIX:ROG
Average EV/EBIT: 1 698.4
11.4
6%
1.9
US
Eli Lilly and Co
NYSE:LLY
40.8
32%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
17.4
14%
1.2
CH
Novartis AG
SIX:NOVN
14.2
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.9
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.5
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1
FR
Sanofi SA
PAR:SAN
5.6
14%
0.4

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
10.5
2-Years Forward
EV/EBIT
10
3-Years Forward
EV/EBIT
9.6